Trump Indicates Iran Deal and Strait of Hormuz Reopening Near Agreement Chinas Push for Humanoid Robot Workforce Raises Competitive Stakes Workday Jumps 5 After Raising Margin Forecast on AIDriven Gains SpaceX Successfully Launches Starship Test Flight After Initial Scrub SP 500 Advances as Healthcare and Tech Lead Communication Services Lags Hitachi Secures Contract for Railway Signaling System in Mexico TR Q3 2023 Earnings EPS of 049 Reported Stock Declines 118 CECO Q1 2026 Earnings EPS Smashes Estimates by 140 Yet Stock Drops on Revenue Concerns PEPG Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline IO Biotech Q3 2025 Earnings EPS Beat Highlights Cost Discipline Amid Ongoing Pipeline Development EXK Q1 2026 Earnings Strong Earnings Beat Propels Silver Producer Despite Tepid Market Reception Oxford Lane Capital Corp 875 Notes 2030 OXLCI Modest Gain Amid Stable Yield Positioning Kearny Financial KRNY Holds Near Support as Trading Remains Subdued Piper Sandler PIPR Edges Lower as Resistance Holds Key Levels in Focus SL Green Realty Corp SLG Gains 252 as Office REIT Shows Resilience AECOM ACM Edges Higher as Infrastructure Momentum Builds Cementos Pacasmayo CPAC Holds Steady at 1052 as Consolidation Persists Near Resistance WaterBridge Infrastructure WBI Slides 5 Key Support Test in Play First Community Corporation FCCO Edges Lower Amid Light Trading as Key Support Levels Hold Caesars Entertainment CZR Edges Up 14 Tests Key Resistance Zone Amid Mixed Sector Signals Lincoln Educational Services LINC Gains 114 as Shares Approach Key Resistance UBS Maintains Buy Rating on Under Armour Amid Market Scrutiny Serve Robotics SERV Q1 2026 Earnings WiderThanExpected Losses Highlight Cost Pressures NVX Surges 11 NOVONIX Limited Tests Resistance at 075 XFLH Capital Corporation XFLH Holds Steady at 1022 as Key Levels Define Trading Range Duos Technologies DUOT Surges 47 Testing Resistance at 1192 Tejon Ranch Co TRC Edges Higher as Real Estate Development Potential Drives Modest Uptick Goldman Sachs BDC GSBD Hovers Near Support as Dividend Appeal Offsets Tepid Volume Actuate Therapeutics ACTU Holds Near Support After Modest Uptick Neumora Therapeutics NMRA Holds Steady at 185 Amid Mixed Sentiment